1. Home
  2. RYTM vs SNDK Comparison

RYTM vs SNDK Comparison

Compare RYTM & SNDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • SNDK
  • Stock Information
  • Founded
  • RYTM 2008
  • SNDK 2024
  • Country
  • RYTM United States
  • SNDK United States
  • Employees
  • RYTM N/A
  • SNDK N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • SNDK
  • Sector
  • RYTM Health Care
  • SNDK
  • Exchange
  • RYTM Nasdaq
  • SNDK NYSE
  • Market Cap
  • RYTM 4.3B
  • SNDK 4.9B
  • IPO Year
  • RYTM 2017
  • SNDK N/A
  • Fundamental
  • Price
  • RYTM $65.25
  • SNDK $45.38
  • Analyst Decision
  • RYTM Strong Buy
  • SNDK Buy
  • Analyst Count
  • RYTM 12
  • SNDK 10
  • Target Price
  • RYTM $77.50
  • SNDK $59.40
  • AVG Volume (30 Days)
  • RYTM 585.3K
  • SNDK 3.7M
  • Earning Date
  • RYTM 08-05-2025
  • SNDK 08-07-2025
  • Dividend Yield
  • RYTM N/A
  • SNDK N/A
  • EPS Growth
  • RYTM N/A
  • SNDK N/A
  • EPS
  • RYTM N/A
  • SNDK N/A
  • Revenue
  • RYTM $136,863,000.00
  • SNDK $7,214,000,000.00
  • Revenue This Year
  • RYTM $37.56
  • SNDK $10.81
  • Revenue Next Year
  • RYTM $74.99
  • SNDK $13.96
  • P/E Ratio
  • RYTM N/A
  • SNDK N/A
  • Revenue Growth
  • RYTM 48.88
  • SNDK 18.53
  • 52 Week Low
  • RYTM $40.46
  • SNDK $27.89
  • 52 Week High
  • RYTM $69.89
  • SNDK $58.36
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 53.08
  • SNDK N/A
  • Support Level
  • RYTM $60.80
  • SNDK N/A
  • Resistance Level
  • RYTM $64.00
  • SNDK N/A
  • Average True Range (ATR)
  • RYTM 1.96
  • SNDK 0.00
  • MACD
  • RYTM -0.13
  • SNDK 0.00
  • Stochastic Oscillator
  • RYTM 44.48
  • SNDK 0.00

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About SNDK SANDISK CORP

SanDisk Corp is one of the five largest suppliers of NAND flash memory semiconductors globally. Sandisk is vertically integrated, producing substantially all of its flash chips at manufacturing sites across Japan via a joint-venture framework with Kioxia. Sandisk then repackages majority of its chips into SSDs for consumer electronics, external storage, or cloud storage. Sandisk was formerly a piece of Western Digital for nine years (after being acquired in 2016) and was spun off as an independent company in 2025.

Share on Social Networks: